VEGFB and autoimmune disease: These data indicate that heightened autocrine VEGF-B signaling in T cells contributes to the development of autoimmune diseases and interventions targeting VEGF-B signaling may offer a potential treatment for autoimmune conditions driven by overactive inflammatory T cells.